NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080220120

Registered date:13/09/2005

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedAtopic dermatitis
Date of first enrollment13/09/2005
Target sample size278
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : Cetirizine INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary OutcomeChange in the severity of pruritus, safety etc.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 3age old
Age maximum<= 14age old
Gender
Include criteriaAge: 3 to 14, Children with atopic dermatitis, patients eligible for evaluation of pruitus, etc.
Exclude criteria

Related Information

Contact

Public contact
Name
Address http://glaxosmithkline.co.jp/contact.html
Telephone
E-mail
Affiliation GlaxoSmithKline K.K.
Scientific contact
Name
Address
Telephone
E-mail
Affiliation